Tyrosine Kinases as Druggable Targets in Cancer
Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL...
Tallennettuna:
| Muut tekijät: | |
|---|---|
| Aineistotyyppi: | Elektroninen Kirjan osa |
| Kieli: | englanti |
| Julkaistu: |
IntechOpen
2019
|
| Aiheet: | |
| Linkit: | DOAB: download the publication DOAB: description of the publication |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|